Back
Vanguard Short-Term Tax-Exempt Bond ETF Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison
Sell
40
VTES
Vanguard Short-Term Tax-Exempt Bond ETF
Last Price:
$101.51
Seasonality Move:
1.31%
Sell
35
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$26.12
Seasonality Move:
0.37%
Sell
40
Vanguard Short-Term Tax-Exempt Bond ETF (VTES)
is a Sell
Is Vanguard Short-Term Tax-Exempt Bond ETF a Buy, Sell or Hold?
-
The current Vanguard Short-Term Tax-Exempt Bond ETF [VTES] share price is $101.51. The Score for VTES is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
VTES is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Sell
Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $25.27. The Score for AMPH is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
AMPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VTES Stock Price Chart
What is Vanguard Short-Term Tax-Exempt Bond ETF's stock price today?
-
The Vanguard Short-Term Tax-Exempt Bond ETF share price today is $101.51Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTES is experiencing slight buying pressure.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals, Inc.'s stock price today?
-
The Amphastar Pharmaceuticals, Inc. share price today is $25.27The current trend is relatively stagnant and AMPH is experiencing selling pressure, which indicates risk of future bearish movement.
VTES Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.11 | Buy |
| Relative Strength Index (14 RSI): | 50.07 | Buy |
| Chaikin Money Flow: | 10603 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.42 - 101.56) | Buy |
| Bollinger Bands (100): | (101.39 - 101.89) | Sell |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 42.93 | Sell |
| Chaikin Money Flow: | -290015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.46 - 27.32) | Sell |
| Bollinger Bands (100): | (23.69 - 28.87) | Sell |
VTES Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 101.47 | Buy |
| 20-day SMA: | 101.5 | Buy |
| 50-day SMA: | 101.56 | Sell |
| 200-day SMA: | 101.02 | Buy |
| 8-day EMA: | 101.17 | Buy |
| 20-day EMA: | 91.33 | Buy |
| 50-day EMA: | 61.05 | Buy |
| 200-day EMA: | 20.85 | Buy |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.26 | Sell |
| 20-day SMA: | 26.42 | Sell |
| 50-day SMA: | 25.51 | Sell |
| 200-day SMA: | 25.69 | Sell |
| 8-day EMA: | 26.03 | Sell |
| 20-day EMA: | 26.21 | Sell |
| 50-day EMA: | 26.07 | Sell |
| 200-day EMA: | 27.97 | Sell |
Vanguard Short-Term Tax-Exempt Bond ETF Earnings Growth & VTES Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and an increase next year of $0.29 per share.
Vanguard Short-Term Tax-Exempt Bond ETF Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||